You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

Drug Price Trends for NDC 62011-0455


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 62011-0455

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

62011-0455 Market Analysis and Financial Projection

Market Analysis and Price Projections for the Drug NDC: 62011-0455

Understanding the NDC Directory

To analyze the market and project prices for a specific drug identified by its National Drug Code (NDC), it is crucial to understand the NDC Directory. The FDA's National Drug Code Directory contains comprehensive information about finished drug products, including prescription and over-the-counter drugs, approved and unapproved drugs, and repackaged or relabeled drugs. Each drug is identified by a unique three-segment NDC number[4].

Identifying the Drug

The NDC 62011-0455 corresponds to a specific drug product. To identify this drug, one would need to search the FDA's NDC Directory, which is updated daily. This directory provides details such as the drug's name, its pharmacological class, the Drug Enforcement Administration (DEA) schedule if applicable, and the labeler (manufacturer or distributor)[4].

Market Trends in Pharmaceutical Prices

Pharmaceutical prices are subject to various market and regulatory factors. Here are some key trends that could influence the price of the drug with NDC 62011-0455:

Price Inflation

Pharmaceutical prices are experiencing significant inflation. According to Vizient's summer Pharmacy Market Outlook, the overall drug price inflation rate for 2025 is projected to be 3.81%. This inflation is partly driven by the expanding indications of previously approved medications, such as semaglutide, which saw a 77% increase in spend since the summer 2023 Outlook[2].

Global Price Comparisons

The United States has notably higher drug prices compared to other regions. In 2022, the average price per unit in the U.S. was 5.5 times higher than in the OECD (excluding the U.S.) and 7.7 times higher than in the rest of the world. This disparity is due to both higher prices for the same drugs and a drug mix that skews towards more expensive compounds[3].

Price Increases Over Time

Drug manufacturers frequently adjust list prices, with many increases exceeding the rate of inflation. From January 2022 to January 2023, over 4,200 drug products had price increases, with an average increase of 15.2% or $590 per drug product. This trend suggests that prices for existing drugs continue to rise, contributing to affordability challenges[5].

Factors Influencing Drug Prices

Several factors can influence the price of a specific drug like the one identified by NDC 62011-0455:

Regulatory Environment

Changes in regulatory policies can impact drug prices. For instance, the Inflation Reduction Act (IRA) provisions aim to control price increases for certain drugs, which could have broader implications for the pharmaceutical market[5].

Market Demand and Supply

The demand for a drug, especially if it has multiple indications or is part of standard care protocols, can drive up prices. For example, the increased use of GLP-1 agents like semaglutide for diabetes, obesity, and cardiovascular disease has significantly impacted pharmacy spend[2].

Competition and Patent Status

The presence of generic or biosimilar alternatives can reduce prices, while drugs under patent protection tend to maintain higher prices. The NDC Directory can help identify if there are generic or branded versions of the drug, which affects pricing dynamics[4].

Price Projections

Given the current market trends and factors influencing drug prices, here are some potential price projection considerations for the drug with NDC 62011-0455:

Short-Term Projections

  • Inflation Adjustments: Expect a price increase in line with the projected 3.81% drug price inflation rate for 2025, assuming the drug is not subject to specific regulatory controls or market disruptions[2].

Long-Term Projections

  • Regulatory Impact: If the drug falls under categories affected by new regulatory measures, such as the IRA provisions, there could be constraints on price increases. However, if the drug is not directly impacted, it may continue to follow general market trends of increasing prices[5].
  • Market Dynamics: If the drug has expanding indications or is integrated into standard care protocols, it could see higher demand and consequently higher prices. Conversely, if generic or biosimilar versions enter the market, prices might decrease[2][4].

Example: Semaglutide Price Trends

To illustrate how these factors can influence price projections, consider the example of semaglutide (NDCs for Ozempic® and Wegovy®). The expanding indications for semaglutide have led to a significant increase in spend, up 77% since the summer 2023 Outlook. This trend suggests that drugs with growing demand and multiple therapeutic uses are likely to see substantial price increases[2].

Key Takeaways

  • NDC Directory: The FDA's NDC Directory is a critical resource for identifying and tracking drug products.
  • Price Inflation: Pharmaceutical prices are expected to rise, with a projected 3.81% inflation rate for 2025.
  • Global Price Disparities: U.S. drug prices are significantly higher than in other regions.
  • Regulatory and Market Factors: Changes in regulations and market demand can significantly impact drug prices.
  • Long-Term Projections: Prices may be influenced by regulatory measures, market competition, and the drug's therapeutic indications.

FAQs

Q: What is the NDC Directory, and how is it used? A: The NDC Directory is a database maintained by the FDA that contains information about finished and unfinished drug products, identified by unique National Drug Codes. It is used to track and regulate drugs in the U.S. market[4].

Q: Why are drug prices in the U.S. higher than in other countries? A: Drug prices in the U.S. are higher due to a combination of higher prices for the same drugs and a drug mix that includes more expensive compounds compared to other regions[3].

Q: How do regulatory changes impact drug prices? A: Regulatory changes, such as those introduced by the Inflation Reduction Act, can control price increases for certain drugs and have broader implications for the pharmaceutical market[5].

Q: What factors drive price increases for specific drugs? A: Factors such as expanding therapeutic indications, market demand, regulatory environment, and the presence of generic or biosimilar alternatives can drive price increases for specific drugs[2][4].

Q: How can one project future prices for a specific drug? A: Future prices can be projected by considering current market trends, regulatory changes, and the specific factors influencing the drug's market dynamics, such as demand and competition[2][5].

Sources

  1. YouTube - NDC Directory (March 2015)
  2. Vizient Inc. - Pharmacy Market Outlook (July 2024)
  3. ASPE - International Market Size and Prices (December 2024)
  4. FDA - National Drug Code Directory (November 2024)
  5. ASPE - Changes in the List Prices of Prescription Drugs, 2017-2023 (October 2023)

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.